JP2002523518A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523518A5
JP2002523518A5 JP2000567569A JP2000567569A JP2002523518A5 JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5 JP 2000567569 A JP2000567569 A JP 2000567569A JP 2000567569 A JP2000567569 A JP 2000567569A JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
acid
hydrophobic amino
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000567569A
Other languages
English (en)
Japanese (ja)
Other versions
JP4528443B2 (ja
JP2002523518A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/019378 external-priority patent/WO2000012553A1/en
Publication of JP2002523518A publication Critical patent/JP2002523518A/ja
Publication of JP2002523518A5 publication Critical patent/JP2002523518A5/ja
Application granted granted Critical
Publication of JP4528443B2 publication Critical patent/JP4528443B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000567569A 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用 Expired - Fee Related JP4528443B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
US60/098,359 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010034833A Division JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Publications (3)

Publication Number Publication Date
JP2002523518A JP2002523518A (ja) 2002-07-30
JP2002523518A5 true JP2002523518A5 (https=) 2006-08-10
JP4528443B2 JP4528443B2 (ja) 2010-08-18

Family

ID=22268937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000567569A Expired - Fee Related JP4528443B2 (ja) 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Country Status (13)

Country Link
EP (1) EP1105420A1 (https=)
JP (2) JP4528443B2 (https=)
KR (1) KR20010079695A (https=)
CN (1) CN1324367A (https=)
AU (1) AU751034B2 (https=)
BR (1) BR9913490A (https=)
CA (1) CA2341810A1 (https=)
CZ (1) CZ2001655A3 (https=)
HU (1) HUP0103265A3 (https=)
IL (1) IL141586A0 (https=)
PL (1) PL204359B1 (https=)
WO (1) WO2000012553A1 (https=)
ZA (1) ZA200102489B (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
IL141586A0 (en) * 1998-08-28 2002-03-10 Myelos Corp Cyclic prosaposin-derived peptide and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
ES2641272T3 (es) 2006-04-28 2017-11-08 Children's Hospital Medical Center Composiciones que comprenden proteínas o polipéptidos fusogénicos derivados de la prosaposina para aplicación en sistemas de suministro de fármacos transmembrana
JP5253402B2 (ja) * 2006-10-20 2013-07-31 チルドレンズ ホスピタル メディカル センター 自発的に形成する楕円体の単層リン脂質小胞
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
WO2016172409A1 (en) 2015-04-23 2016-10-27 The Procter & Gamble Company Delivery of surfactant soluble anti-dandruff agent
MX379907B (es) 2016-03-03 2025-03-11 Procter & Gamble Composicion anticaspa en aerosol.
WO2018075846A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam designating hair conditioning benefits
BR112019007682B1 (pt) 2016-10-21 2022-08-16 The Procter & Gamble Company Produtos de xampu compactos estáveis com baixa viscosidade e agente redutor de viscosidade
EP3528896A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
EP3528774A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair volume benefits
EP3528894A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
CN109843383A (zh) 2016-10-21 2019-06-04 宝洁公司 用于在最佳制剂空间中递送消费者期望的剂量体积、表面活性剂量和头皮健康剂量的泡沫剂型
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
MX388495B (es) 2017-10-10 2025-03-20 Procter & Gamble Composición de champú compacto que contiene surfactantes libres de sulfato.
CN111278418A (zh) 2017-10-10 2020-06-12 宝洁公司 具有基于氨基酸的阴离子表面活性剂和阳离子聚合物的致密型洗发剂组合物
CN111278416A (zh) 2017-10-10 2020-06-12 宝洁公司 含低无机盐的无硫酸盐个人清洁组合物
EP3694479B1 (en) 2017-10-10 2026-01-14 The Procter & Gamble Company A method of treating hair or skin with a personal care composition in a foam form
EP3727323B1 (en) 2017-12-20 2026-04-29 The Procter & Gamble Company Clear shampoo composition containing silicone polymers
US11318073B2 (en) 2018-06-29 2022-05-03 The Procter And Gamble Company Low surfactant aerosol antidandruff composition
US12226505B2 (en) 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
CN114746153A (zh) 2019-12-06 2022-07-12 宝洁公司 具有增强头皮活性物质沉积的不含硫酸盐的组合物
CN115151310B (zh) 2020-02-27 2024-12-20 宝洁公司 功效和美观性增强的含硫去头皮屑组合物
CA3198853A1 (en) 2020-11-23 2022-05-27 The Procter & Gamble Company Personal care compositions free of sulfated surfactants
MX2023005963A (es) 2020-12-04 2023-06-07 Procter & Gamble Composiciones para el cuidado del cabello que comprenden materiales de reduccion del mal olor.
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
CA3235522A1 (en) 2021-12-09 2023-06-15 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106106A0 (en) * 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
IL141586A0 (en) * 1998-08-28 2002-03-10 Myelos Corp Cyclic prosaposin-derived peptide and uses thereof

Similar Documents

Publication Publication Date Title
JP2002523518A5 (https=)
JP3266311B2 (ja) 新規ポリペプチドおよびこれを用いる抗hiv剤
AU714846B2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
US5854211A (en) Compounds with growth hormone releasing properties
US5470828A (en) Peptide analogs of insulin-like growth factor II
CA2308116A1 (en) Low-toxicity human interferon-alpha analog
ATE206716T1 (de) Cyclische wirkstoff-vorläufer verbindungen von peptiden und peptid-nukleicsäuren mit verbesserter metabolischer stabilität und zellmembran permeabilität
EP1025840A3 (en) Oral drug compositions and methods
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
JP2002524393A5 (https=)
DE69227462D1 (de) Peptide mit wachstumshormonfreisetzender aktivität
CA2332817A1 (en) Il-6 antagonist peptides
Fujino et al. Syntheses and biological activities of analogs of luteinizing hormone releasing hormone (LH-RH)
JP2004531242A5 (https=)
JPH0273100A (ja) 医薬用化合物
RU2000109265A (ru) Лечение ожирения
CA2311648A1 (en) Ifnar2/ifn complex
US4684624A (en) Method of treating cerebral ischemia
HUT77979A (hu) Peptidek, előállításuk és ezeket tartalmazó gyógyszerkészítmények
ITMI952681A1 (it) Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
DE60133654D1 (de) Arzneimittel enthaltend analgetische peptide
US5807985A (en) Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
CA2465667A1 (en) New peptides - analogs of human growth hormone-releasing hormone
IE58407B1 (en) Peptides
SE446867B (sv) Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter